Have a question?

Call us on
0800 05 16 384
(UK toll-free)
1800 552 197 (IR toll-free)

EXOGEN® News

NTAC Releases Adoption Pack to Assist Implementation of NICE Guidelines Supporting the Use of EXOGEN

HOOFDDORP, THE NETHERLANDS, 5/13/2013

The NHS Technology Adoption Centre (NTAC), the implementation arm of the National Institute for Health and Care Excellence (NICE), recently launched a new Adoption Pack regarding the EXOGEN Ultrasound Bone Healing System.

The NHS Technology Adoption Centre (NTAC), the implementation arm of the National Institute for Health and Care Excellence (NICE), recently launched a new Adoption Pack regarding the EXOGEN Ultrasound Bone Healing System.

The new adoption pack is designed to help NHS Trusts correctly implement guidelines NICE released (guidance MTG12) supporting the use of EXOGEN as an alternative to surgery for thousands of patients with long bone non-union fractures. The pack includes information about the benefits of EXOGEN to patients/physicians/healthcare systems, the national and local opportunities available, the drivers for adoption, detailed case studies of where EXOGEN has already been successfully used in the NHS, and the costs and potential savings.

NTAC’s experience of working with NHS clinicians, managers and commissioners ensures the information and advice contained within the Adoption Pack is accurate and useful for the NHS.

EXOGEN, which is manufactured and distributed worldwide by Bioventus LLC, uses a unique low-intensity pulsed ultrasound signal to stimulate broken bones to heal naturally, in comparison to surgical management. Patients using EXOGEN place an ultrasound probe on the skin for 20 minutes a day and the treatment, done at home, is entirely pain free with no known side effects. Clinical studies have shown EXOGEN to have an equivalent 86% success rate as surgery4.

The device is used by physicians around the world including many of the UK’s leading surgeons, a number of which have been interviewed for the Adoption Pack. One of these is Angus MacLean, Senior Orthopaedic Consultant at Glasgow Royal Infirmary, who said: “By accelerating health there is significant potential for this technology to save money for the NHS by reducing the need for surgery and returning patients to work more quickly than before. Cost savings and clinical effectiveness therefore make a potential ‘win-win’ situation for the NHS and the patient.”

The full implementation pack can be downloaded at the NTAC website.

  • High treatment
    compliance21
  • +
  • Proven clinical
    effectiveness2-4
  • > >
  • Successful fracture
    healing outcomes